Streetbeat News

Products Services

CYD

China Yuchai International Limited (NYSE:CYD), a leading manufacturer and distributor of engines, announced that its subsidiary, Yuchai Xin-Lan, has launched a hybrid powertrain system for SANY Group's mixer trucks. The new system is expected to result in high fuel savings.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 10:03 am

PBLA

Panbela Therapeutics has announced an issue notification for the Australian patent for claims of a novel process for the production of SBP-101. The patent is valid until 2039.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 10:02 am

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares rose in premarket trading on Monday, potentially extending its winning streak to a fifth straight session. This is due to investor optimism following the company's confirmation that the first Cybertruck has rolled off the production line at its Giga Texas plant. Analysts expect the Cybertruck to boost the company's volume when production ramps up in 2024. Investors are also looking forward to Tesla's Q2 earnings report due Wednesday, with expectations of adjusted earnings per share of $0.81 and revenue of $24.53 billion.

Portfolio Pulse from Shanthi Rexaline

July 17, 2023 | 9:58 am

TSLA

Tesla Inc's CEO Elon Musk praised the company's Model S car, calling it 'pure joy on tap'. This comes in response to a user's positive review of the Model S Plaid, which she termed as the best and safest vehicle she has ever driven. Musk has previously described the Model S Plaid with various positive terms. The high-performance version of Tesla's flagship electric sedan started deliveries in 2021. In June, Tesla announced that the Model S Plaid set a new lap record for a production electric vehicle at Nürburgring, beating the previous record set by Porsche's Taycan Turbo S.

Portfolio Pulse from Anan Ashraf

July 17, 2023 | 9:56 am

FSLR

First Solar Inc (FSLR) has signed a contract with Energix Renewables to supply 5 GWDC ultra-low carbon thin film solar modules between 2026 and 2030. The modules will power Energix projects in Israel, Poland, and the U.S. FSLR also plans to invest $1.3 billion to increase its U.S. manufacturing capacity to 10.9 GWDC by 2026. The company's shares are trading higher by 0.44% at $192.14 premarket.

Portfolio Pulse from Lekha Gupta

July 17, 2023 | 9:54 am

ARKK

GS

TSLA

Over the weekend, Tesla's first Cybertruck rolled off the production line at the Giga Texas plant, which is expected to significantly boost Tesla's volume. Elon Musk expressed doubts about Vice President Kamala Harris serving as the AI czar. Former President Donald Trump was reportedly upset as his son-in-law testified before a grand jury. Macro guru Raoul Pal warned of a looming crisis, and a Wall Street strategist issued a troubling assessment of the stock market rally. Ark Invest founder Cathie Wood discussed the year-to-date performance of the firm’s actively-managed exchange-traded funds.

Portfolio Pulse from Benzinga Neuro

July 17, 2023 | 9:49 am

AAPL

Apple Inc. is expected to launch M3-powered iMac, MacBook Air, and MacBook Pro devices in October. The M3 chipset, developed in collaboration with Taiwan Semiconductor Manufacturing Company Limited, is expected to significantly improve performance due to a shift from a 5-nanometer silicon fabrication process to a 3-nanometer process. Before the M3-powered Macs debut, Apple is expected to launch its new iPhone 15 series and an updated Apple Watch lineup.

Portfolio Pulse from Ananya Gairola

July 17, 2023 | 9:38 am

NVO

Biotechnology company Eleven Therapeutics has announced a research collaboration with global healthcare company Novo Nordisk. The collaboration aims to identify novel molecules for precise delivery of nucleic acid using Eleven's DELiveri™ platform, targeting cardiometabolic diseases.

Portfolio Pulse from Charles Gross

July 17, 2023 | 9:26 am

ABOS

Acumen Pharmaceuticals presented positive topline results from its Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 8:53 am

ABOS

Acumen Pharmaceuticals presented topline results from its Phase 1 study of ACU193 for early Alzheimer's disease. The trial met both primary and secondary objectives.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 8:52 am